Tempest Therapeutics Files 8-K with Material Agreement
Ticker: TPST · Form: 8-K · Filed: Jun 12, 2025 · CIK: 1544227
| Field | Detail |
|---|---|
| Company | Tempest Therapeutics, Inc. (TPST) |
| Form Type | 8-K |
| Filed Date | Jun 12, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, 8-K, disclosure
Related Tickers: TPST
TL;DR
Tempest Therapeutics (TPST) filed an 8-K on 6/11/25, signaling a material definitive agreement and other key events.
AI Summary
On June 11, 2025, Tempest Therapeutics, Inc. entered into a material definitive agreement. The company also made a Regulation FD disclosure and reported other events, including financial statements and exhibits. This filing pertains to Tempest Therapeutics, Inc., incorporated in Delaware.
Why It Matters
This 8-K filing indicates a significant development for Tempest Therapeutics, Inc., potentially impacting its operations, partnerships, or financial standing.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities, and the nature of these events requires further investigation.
Key Players & Entities
- Tempest Therapeutics, Inc. (company) — Registrant
- June 11, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 451472564 (identifier) — EIN
FAQ
What is the nature of the material definitive agreement entered into by Tempest Therapeutics, Inc. on June 11, 2025?
The filing states that Tempest Therapeutics, Inc. entered into a material definitive agreement on June 11, 2025, but the specific details of this agreement are not provided in the provided text.
What other events are reported in this 8-K filing?
Besides the material definitive agreement, the filing also includes a Regulation FD disclosure, other events, and financial statements and exhibits.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on June 11, 2025.
In which state is Tempest Therapeutics, Inc. incorporated?
Tempest Therapeutics, Inc. is incorporated in Delaware.
What is the EIN of Tempest Therapeutics, Inc. as listed in the filing?
The EIN of Tempest Therapeutics, Inc. is 451472564.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 12, 2025 regarding Tempest Therapeutics, Inc. (TPST).